Bloodstream infections and mortality-related factors in febrile neutropenic cancer patients
- PMID: 21525814
- PMCID: PMC3539578
- DOI: 10.12659/msm.881773
Bloodstream infections and mortality-related factors in febrile neutropenic cancer patients
Abstract
Background: We performed a prospective observational cohort study to evaluate the causative bacteria and to identify risk factors for mortality in febrile neutropenic (FN) patients with blood stream infection (BSI).
Material/methods: We conducted a prospective data collection on all patients with bacteremia or fungemia. The patients were assigned into low-risk and high-risk groups in accordance with the Multinational Association for Supportive Care in Cancer (MASCC) Risk Index.
Results: Throughout the study period, the patients developed 420 FN episodes. Out of 420 episodes, only 90 (21.4%) were found to have bloodstream infection. The mean age of the patients was 45.6±18.4 years and 55.6% of the patients were male. A total of 98 isolates were recovered from the cases of BSI. Coagulase-negative Staphylococcus spp (CoNS) were the most common isolates overall (33.7%). There was a significant increase in the rate of gram-negative bacteria throughout the study period (p=0.028). Overall mortality was 33%. Multivariate analyses showed that MASCC risk scores (p=0.0001, OR=15.1, CI%95 4.5-50.7), ICU wards (p=0.0002, OR= 8.6, Cl%95 1.101-68,157) and CoNS (p=0.004, OR=12.12, CI%95 2.3-64.7) were independent risk factors associated with mortality. BSI due to CoNS was associated with lower mortality; however, MASCC high risk score and ICU stay were associated with higher mortality.
Conclusions: The MASCC risk-index score and emergence of CoNS in positive blood cultures are valuable tools in the management of FN.
Figures
References
-
- Petrilli AS, Melaragno R, Barros KV, et al. Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease. Pediatr Infect Dis J. 1993;12(11):916–21. - PubMed
-
- Oude Nijhuis C, Kamps WA, Daenen SM, et al. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. J Clin Oncol. 2005;23(30):7437–44. - PubMed
-
- Santolaya ME, Villarroel M, Avendano LF, Cofre J. Discontinuation of antimicrobial therapy for febrile neutropenic children with cancer: a prospective study. Clin Infect Dis. 1997;25(1):92–97. - PubMed
-
- Morris PG, Hassan T, McNamara M, et al. Emergence of MRSA in positive blood cultures from patients with febrile neutropenia a cause for concern. Support Care Cancer. 2008;16(9):1085–88. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous